Literature DB >> 9803469

Effect of pamidronate on bone blood flow in oophorectomized rats.

J Kapitola1, J Zák.   

Abstract

In connection with the known inhibitive action of bisphosphonates on bone resorption we were interested in their possible influence on bone blood flow (BBF). We determined BBF (85Sr-microsphere uptake in the tibia, distal femur and diaphysis of femur), cardiac output, density and ash weight of the tibia, as well as 24-h incorporation of 45Ca and 3H-proline into the tibia. Pamidronate (Aredia, CIBA-Geigy, Switzerland) was administered to sham-operated or oophorectomized (OOX) female rats in doses of 0.6 mg i.p. 2 days a week for 4 weeks. 85Sr-microsphere uptake was increased after OOX in the tibia and distal femur, simultaneous pamidronate administration significantly suppressed this increase below the control level. In addition, pamidronate inhibited the 24-h incorporation of 45Ca and 3H-proline in sham-operated females and suppressed the incorporation of 3H-proline that was increased after OOX. Bone density and ash weight were significantly increased after pamidronate administration in both sham-operated and OOX rats. The results of both experiments showing a significant effect of pamidronate on BBF and incorporation of 45Ca and 3H-proline require further verification and elucidation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9803469

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  6 in total

1.  Jaw complications associated with bisphosphonate use in patients with plasma cell dyscrasias.

Authors:  S G Thakkar; C Isada; J Smith; M A Karam; J Reed; J W Tomford; K Englund; M Richmond; A Licata; C Hatch; M A Hussein
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

2.  Effects of high dose of zoledronic acid on superficial vascular network of membranous bone sites: an intravital study on rat calvarium.

Authors:  M H Vieillard; J Paccou; B Cortet; E Biver; J Salleron; G Falgayrac; G Penel
Journal:  Osteoporos Int       Date:  2009-12-18       Impact factor: 4.507

Review 3.  Potential pathophysiological mechanisms in osteonecrosis of the jaw.

Authors:  Regina Landesberg; Victoria Woo; Serge Cremers; Matthew Cozin; Darja Marolt; Gordana Vunjak-Novakovic; Stavroula Kousteni; Srikala Raghavan
Journal:  Ann N Y Acad Sci       Date:  2011-02       Impact factor: 5.691

4.  Serum Markers of Bone Turnover and Angiogenesis in Patients With Bisphosphonate-Related Osteonecrosis of the Jaw After Discontinuation of Long-Term Intravenous Bisphosphonate Therapy.

Authors:  Vivek Thumbigere-Math; Bryan S Michalowicz; Pamela J Hughes; David L Basi; Michaela L Tsai; Karen K Swenson; Laura Rockwell; Rajaram Gopalakrishnan
Journal:  J Oral Maxillofac Surg       Date:  2015-10-03       Impact factor: 1.895

5.  Oral health condition in cancer patients under bisphosphonate therapy.

Authors:  Rogério Jardim Caldas; Héliton Spíndola Antunes; Camila de Oliveira Rodini Pegoraro; Fábio Ribeiro Guedes; Paulo Sérgio da Silva Santos
Journal:  Support Care Cancer       Date:  2021-06-18       Impact factor: 3.603

6.  Assessment of regional bone tissue perfusion in rats using fluorescent microspheres.

Authors:  Mohammad W Aref; Ethan Akans; Matthew R Allen
Journal:  Bone Rep       Date:  2017-04-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.